chr17-8312073-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_173728.4(ARHGEF15):āc.34C>Gā(p.Pro12Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00000694 in 144,014 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000069 ( 0 hom., cov: 28)
Exomes š: 0.0000057 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ARHGEF15
NM_173728.4 missense
NM_173728.4 missense
Scores
1
8
10
Clinical Significance
Conservation
PhyloP100: 3.82
Genes affected
ARHGEF15 (HGNC:15590): (Rho guanine nucleotide exchange factor 15) Rho GTPases play a fundamental role in numerous cellular processes that are initiated by extracellular stimuli that work through G protein-coupled receptors. This gene encodes a protein that functions as a specific guanine nucleotide exchange factor for RhoA. It also interacts with ephrin A4 in vascular smooth muscle cells. Two alternatively spliced transcripts variants that encode the same protein have been found for this gene. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARHGEF15 | NM_173728.4 | c.34C>G | p.Pro12Ala | missense_variant | 2/16 | ENST00000361926.8 | NP_776089.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARHGEF15 | ENST00000361926.8 | c.34C>G | p.Pro12Ala | missense_variant | 2/16 | 1 | NM_173728.4 | ENSP00000355026 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000694 AC: 1AN: 144014Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
1
AN:
144014
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000138 AC: 3AN: 217432Hom.: 0 AF XY: 0.0000171 AC XY: 2AN XY: 117256
GnomAD3 exomes
AF:
AC:
3
AN:
217432
Hom.:
AF XY:
AC XY:
2
AN XY:
117256
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000566 AC: 7AN: 1237354Hom.: 0 Cov.: 34 AF XY: 0.00000488 AC XY: 3AN XY: 614374
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
7
AN:
1237354
Hom.:
Cov.:
34
AF XY:
AC XY:
3
AN XY:
614374
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000694 AC: 1AN: 144014Hom.: 0 Cov.: 28 AF XY: 0.0000143 AC XY: 1AN XY: 69932
GnomAD4 genome
AF:
AC:
1
AN:
144014
Hom.:
Cov.:
28
AF XY:
AC XY:
1
AN XY:
69932
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Early infantile epileptic encephalopathy with suppression bursts Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 14, 2023 | ClinVar contains an entry for this variant (Variation ID: 530538). This sequence change replaces proline, which is neutral and non-polar, with alanine, which is neutral and non-polar, at codon 12 of the ARHGEF15 protein (p.Pro12Ala). This variant is present in population databases (rs150480540, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with ARHGEF15-related conditions. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Benign
DEOGEN2
Benign
.;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;.;T;T
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Uncertain
.;M;.;M
MutationTaster
Benign
N;N
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N;.;N
REVEL
Uncertain
Sift
Pathogenic
.;D;.;D
Sift4G
Benign
T;D;T;D
Polyphen
1.0
.;D;.;D
Vest4
0.38, 0.38
MVP
MPC
0.44
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at